+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Treanda"

Non Hodgkin's Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Non Hodgkin's Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
B Cell Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

B Cell Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 131 Pages
  • Global
From
Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029 - Product Thumbnail Image

Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029

  • Report
  • April 2023
  • 260 Pages
  • Global
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Gazyva - Product Thumbnail Image

Gazyva

  • Report
  • January 2019
  • 40 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Treanda - API Insight, 2022 - Product Thumbnail Image

Treanda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Treanda is a chemotherapy drug used to treat certain types of leukemia, including chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). It is a type of alkylating agent, which works by interfering with the growth of cancer cells. Treanda is administered intravenously and is usually given in combination with other drugs. It is also used to treat certain types of lymphoma and multiple myeloma. Treanda is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2014. It is marketed by Teva Pharmaceuticals and is available in both generic and branded forms. Other companies that produce Treanda include Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more